Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Advicenne

ALDVI
Current price
2 EUR 0 EUR (0.00%)
Last closed 1.9 EUR
ISIN FR0013296746
Sector Healthcare
Industry Biotechnology
Exchange Euronext Paris
Capitalization 24 031 809 EUR
Yield for 12 month +2.56 %
1Y
3Y
5Y
10Y
15Y
ALDVI
21.11.2021 - 28.11.2021

Advicenne S.A., a specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases. Its main drug candidate is Sibnayal, which has completed phase III clinical trial for the treatment of distal renal tubular acidosis, as well as cystinuria. The company also distributes Likozam, a formulation of clobazam for the treatment of short-term symptomatic of severe, disabling, or condition-causing anxiety unacceptable distress; and Levidcen, a galenic form of levetiracetam for the treatment of epileptic seizures. Advicenne S.A. was incorporated in 2007 and is headquartered in Paris, France. Address: 3ème étage 262, Paris, France, 75008

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.74 EUR

P/E ratio

Dividend Yield

Current Year

+4 450 131 EUR

Last Year

+2 392 769 EUR

Current Quarter

+882 939 EUR

Last Quarter

+882 939 EUR

Current Year

+2 728 176 EUR

Last Year

+1 277 741 EUR

Current Quarter

+350 380 EUR

Last Quarter

+350 380 EUR

Key Figures ALDVI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 900 798 EUR
Operating Margin TTM -271.23 %
PE Ratio
Return On Assets TTM -57 %
PEG Ratio
Return On Equity TTM -10277.78 %
Wall Street Target Price 6.74 EUR
Revenue TTM 3 327 117 EUR
Book Value -1.42 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 3.9 %
Dividend Yield
Gross Profit TTM 1 822 777 EUR
Earnings per share -0.75 EUR
Diluted Eps TTM -0.75 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -264.93 %

Dividend Analytics ALDVI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALDVI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1049:1030
Payout Ratio
Last Split Date 13.09.2023
Dividend Date

Stock Valuation ALDVI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 11.709
Price Sales TTM 7.223
Enterprise Value EBITDA -5.4968
Price Book MRQ 127.7049

Financials ALDVI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALDVI

For 52 weeks

0.83 EUR 3.07 EUR
50 Day MA 1.33 EUR
Shares Short Prior Month
200 Day MA 1.66 EUR
Short Ratio
Shares Short
Short Percent